Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight
Portfolio Pulse from Vandana Singh
The U.S. Supreme Court is reviewing a bankruptcy settlement involving Purdue Pharma and the Sackler family over the opioid crisis. Purdue filed for Chapter 11 in 2019 due to lawsuits alleging OxyContin's role in the crisis. The settlement could grant the Sacklers immunity for a financial contribution, sparking debate over bankruptcy law's use to protect individuals from mass-tort liabilities. Initially approved in 2021, the settlement offers $10 billion to creditors. The Biden administration opposes the deal, citing abuse of bankruptcy protections, noting the Sacklers withdrew $11 billion from Purdue before the $6 billion settlement. The 2nd U.S. Circuit Court upheld the settlement, but protests continue against the Sacklers.
December 04, 2023 | 4:29 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cigna Corporation, as a health service company, may face indirect implications from the Purdue Pharma settlement due to its role in healthcare and potential involvement in opioid crisis-related claims.
Cigna Corporation is not directly mentioned in the article, but as a health service company, it may have indirect implications from the settlement due to its potential involvement in opioid crisis-related claims. The impact is likely neutral in the short term as the settlement does not directly involve Cigna.
CONFIDENCE 60
IMPORTANCE 40
RELEVANCE 30
NEUTRAL IMPACT
CVS Health Corporation, being a pharmacy services provider, could be indirectly affected by the Purdue Pharma settlement, potentially influencing its legal and financial responsibilities related to the opioid crisis.
CVS Health Corporation is not directly mentioned in the article, but as a pharmacy services provider, it could be indirectly affected by the settlement, potentially influencing its legal and financial responsibilities related to the opioid crisis. The short-term impact is likely neutral as the settlement does not directly involve CVS.
CONFIDENCE 60
IMPORTANCE 40
RELEVANCE 30
NEUTRAL IMPACT
Quest Diagnostics, a provider of diagnostic information services, may see indirect effects from the Purdue Pharma settlement due to potential changes in healthcare practices and liability concerns.
Quest Diagnostics is not directly mentioned in the article, and as a diagnostic information services provider, its connection to the opioid crisis is tangential. The settlement may have indirect effects on healthcare practices and liability concerns, but the short-term impact on Quest Diagnostics is likely neutral.
CONFIDENCE 50
IMPORTANCE 30
RELEVANCE 20
NEUTRAL IMPACT
Humana Inc., as a health insurance company, could be indirectly impacted by the Purdue Pharma settlement, potentially affecting its coverage policies and financial exposure to opioid-related claims.
Humana Inc. is not directly mentioned in the article, but as a health insurance company, it could be indirectly impacted by the settlement, potentially affecting its coverage policies and financial exposure to opioid-related claims. The short-term impact is likely neutral as the settlement does not directly involve Humana.
CONFIDENCE 60
IMPORTANCE 40
RELEVANCE 30
NEUTRAL IMPACT
UnitedHealth Group, through its health insurance and health services divisions, may face indirect implications from the Purdue Pharma settlement, potentially impacting its healthcare strategies and financial liabilities.
UnitedHealth Group is not directly mentioned in the article, but through its health insurance and health services divisions, it may face indirect implications from the settlement, potentially impacting its healthcare strategies and financial liabilities. The short-term impact is likely neutral as the settlement does not directly involve UnitedHealth.
CONFIDENCE 60
IMPORTANCE 40
RELEVANCE 30
NEUTRAL IMPACT
Walgreens Boots Alliance, as a retail pharmacy chain, could be indirectly affected by the Purdue Pharma settlement, potentially influencing its legal stance and responsibilities in the opioid crisis.
Walgreens Boots Alliance is not directly mentioned in the article, but as a retail pharmacy chain, it could be indirectly affected by the settlement, potentially influencing its legal stance and responsibilities in the opioid crisis. The short-term impact is likely neutral as the settlement does not directly involve Walgreens.
CONFIDENCE 60
IMPORTANCE 40
RELEVANCE 30